For adolescent boys with fatty liver disease, cutting out added sugars and fruit juice for 8 weeks significantly reduced the amount of fat in their liver compared to those who continued their normal diet, indicating that sugar intake directly affects liver fat levels in this group.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether restricting free sugar intake consistently reduces hepatic steatosis across diverse pediatric NAFLD populations, including girls and different ethnicities, and whether this translates to long-term clinical benefits like reduced fibrosis or cirrhosis.
A systematic review and meta-analysis of all randomized controlled trials in children and adolescents with NAFLD comparing low-free-sugar diets (<3% of calories) to control diets, using MRI-PDFF as the primary outcome, with subgroup analyses by sex, ethnicity, baseline sugar intake, and duration of intervention (minimum 12 weeks).
Whether a low-free-sugar diet reduces liver fat in adolescent girls and non-Hispanic children with NAFLD, and whether the effect persists beyond 8 weeks with real-world dietary adherence.
A multicenter, double-blind, placebo-controlled RCT of 200 adolescents (100 boys, 100 girls, aged 11–17) with biopsy-confirmed NAFLD, randomized to either a low-free-sugar diet (<3% calories) with meal provision or a matched-control diet with placebo food delivery, measuring MRI-PDFF and liver fibrosis markers at 12, 24, and 52 weeks.
Whether sustained reduction in free sugar intake over years leads to lower incidence of advanced liver fibrosis, type 2 diabetes, or cardiovascular disease in adolescents previously diagnosed with NAFLD.
A prospective cohort study following 500 adolescents with NAFLD for 10 years, tracking free sugar intake via repeated dietary assessments and measuring liver fibrosis via transient elastography or MRI-PDFF annually, adjusting for BMI, physical activity, and genetic risk factors.
Whether adolescents with progressive NAFLD (fibrosis stage ≥F2) have significantly higher lifetime free sugar intake compared to those with stable disease (F0-F1), after controlling for total calories and obesity.
A case-control study comparing 100 adolescents with biopsy-proven advanced fibrosis (F2–F4) to 100 with mild steatosis (F0–F1), matched for age, sex, BMI, and ethnicity, using validated dietary recall and biomarkers to estimate lifetime free sugar exposure.
Whether higher current free sugar intake correlates with greater liver fat content in a representative sample of adolescents with NAFLD, independent of BMI and total energy intake.
A cross-sectional analysis of 1,000 adolescents with NAFLD across diverse U.S. populations, measuring free sugar intake via 3-day dietary records and liver fat via MRI-PDFF, adjusting for age, sex, ethnicity, BMI, and physical activity.